Search Results
Advertisement
Your search for Louis M. Staudt, MD, PhD, and Wyndham H. Wilson, MD, PhD matches 2 pages
Showing 1 - 2Phase III Trials and Tribulations
Imagine this. You are a large pharmaceutical company that launches an international randomized phase III trial to assess whether one of your drugs improves the outcome of patients with a common type of cancer. The trial was solidly backed by preclinical evidence that the drug target was essential ...
Repurposing Drugs for the Treatment of COVID-19
A vaccine for COVID-19 is currently the Holy Grail, but even if an effective vaccine were developed on a fast-track timetable, it may be effective in only a percentage of people, judging by existing flu vaccines, which show efficacy rates of approximately 45% and vary year by year. Until we have a...
Advertisement
Advertisement
Apr
Today In Oncology23
Advertisement
© 2024 HSP News Service, L.L.C.
